Sara Abdelfatah

3.5k total citations
32 papers, 621 citations indexed

About

Sara Abdelfatah is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Sara Abdelfatah has authored 32 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Sara Abdelfatah's work include Computational Drug Discovery Methods (8 papers), Natural product bioactivities and synthesis (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Sara Abdelfatah is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Natural product bioactivities and synthesis (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Sara Abdelfatah collaborates with scholars based in Germany, Cameroon and Japan. Sara Abdelfatah's co-authors include Thomas Efferth, Janine Naß, Nuha Mahmoud, Edmond Fleischer, Anette Klinger, Victor Kuete, Alexander Panossian, Angela Berg, Godloves Fru and Armelle T. Mbaveng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Sara Abdelfatah

30 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Abdelfatah Germany 17 367 109 79 79 79 32 621
Věra Králová Czechia 16 337 0.9× 122 1.1× 83 1.1× 63 0.8× 58 0.7× 28 683
Iqra Sarfraz Pakistan 14 398 1.1× 53 0.5× 114 1.4× 80 1.0× 91 1.2× 23 816
Simiao Fan China 18 433 1.2× 113 1.0× 44 0.6× 67 0.8× 130 1.6× 34 730
Wafaa S. Ramadan United Arab Emirates 14 346 0.9× 103 0.9× 53 0.7× 60 0.8× 47 0.6× 39 627
Sicheng Liang China 16 382 1.0× 92 0.8× 80 1.0× 97 1.2× 176 2.2× 53 801
Ibrahim Malami Nigeria 16 290 0.8× 81 0.7× 74 0.9× 54 0.7× 130 1.6× 60 721
Adam Skarka Czechia 13 307 0.8× 105 1.0× 59 0.7× 102 1.3× 69 0.9× 30 624
Zhiguo Hou China 17 317 0.9× 44 0.4× 54 0.7× 54 0.7× 108 1.4× 46 675
Md Shahinozzaman United States 19 530 1.4× 92 0.8× 242 3.1× 82 1.0× 44 0.6× 38 939
Preeti Gupta India 15 420 1.1× 74 0.7× 39 0.5× 65 0.8× 44 0.6× 28 688

Countries citing papers authored by Sara Abdelfatah

Since Specialization
Citations

This map shows the geographic impact of Sara Abdelfatah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Abdelfatah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Abdelfatah more than expected).

Fields of papers citing papers by Sara Abdelfatah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Abdelfatah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Abdelfatah. The network helps show where Sara Abdelfatah may publish in the future.

Co-authorship network of co-authors of Sara Abdelfatah

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Abdelfatah. A scholar is included among the top collaborators of Sara Abdelfatah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Abdelfatah. Sara Abdelfatah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Abdelfatah, Sara, et al.. (2023). Coronavirus Inhibitors Targeting nsp16. Molecules. 28(3). 988–988. 9 indexed citations
5.
Naß, Janine, Sara Abdelfatah, & Thomas Efferth. (2021). Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A. Phytomedicine. 84. 153482–153482. 18 indexed citations
6.
Fischer, Nicolas, Ean‐Jeong Seo, Sara Abdelfatah, et al.. (2021). A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy. Investigational New Drugs. 39(4). 914–927. 7 indexed citations
7.
8.
Panossian, Alexander, Sara Abdelfatah, & Thomas Efferth. (2021). Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics. Pharmaceuticals. 14(10). 1010–1010. 15 indexed citations
9.
Abdelfatah, Sara, et al.. (2020). Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells. Phytomedicine. 80. 153371–153371. 78 indexed citations
10.
Mbaveng, Armelle T., Godloves Fru, Sara Abdelfatah, et al.. (2020). Cytotoxicity of a naturally occuring spirostanol saponin, progenin III, towards a broad range of cancer cell lines by induction of apoptosis, autophagy and necroptosis. Chemico-Biological Interactions. 326. 109141–109141. 28 indexed citations
11.
12.
Mbaveng, Armelle T., Simplice B. Tankeo, Sara Abdelfatah, et al.. (2020). The alkaloid, soyauxinium chloride, displays remarkable cytotoxic effects towards a panel of cancer cells, inducing apoptosis, ferroptosis and necroptosis. Chemico-Biological Interactions. 333. 109334–109334. 22 indexed citations
13.
Mbaveng, Armelle T., Simplice B. Tankeo, Sara Abdelfatah, et al.. (2020). 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells. Phytomedicine. 70. 153215–153215. 21 indexed citations
14.
Abdelfatah, Sara, Edmond Fleischer, Anette Klinger, Vincent Kam Wai Wong, & Thomas Efferth. (2019). Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds. Investigational New Drugs. 38(1). 1–9. 10 indexed citations
15.
Abdelfatah, Sara, Xiaohua Lu, Guillermo Schmeda‐Hirschmann, & Thomas Efferth. (2019). Cytotoxicity and antimitotic activity of Rhinella schneideri and Rhinella marina venoms. Journal of Ethnopharmacology. 242. 112049–112049. 16 indexed citations
16.
Abdelfatah, Sara, Angela Berg, Qi Huang, et al.. (2019). MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate. Acta Pharmaceutica Sinica B. 9(5). 1021–1034. 30 indexed citations
17.
Gruber, Lisa, Sara Abdelfatah, Tony Fröhlich, et al.. (2018). Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds. Molecules. 23(4). 841–841. 26 indexed citations
18.
Hegazy, Mohamed‐Elamir F., Ahmed R. Hamed, Ali M. El‐Halawany, et al.. (2018). Cytotoxicity of abietane diterpenoids from Salvia multicaulis towards multidrug-resistant cancer cells. Fitoterapia. 130. 54–60. 17 indexed citations
19.
Hegazy, Mohamed‐Elamir F., Sara Abdelfatah, Ahmed R. Hamed, et al.. (2018). Cytotoxicity of 40 Egyptian plant extracts targeting mechanisms of drug-resistant cancer cells. Phytomedicine. 59. 152771–152771. 38 indexed citations
20.
Abdelfatah, Sara & Thomas Efferth. (2015). Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. Phytomedicine. 22(2). 308–318. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026